Dr. Thomas Barnard, MD
What this data tells you about Dr. Barnard
Dr. Thomas Barnard is a retina specialist (ophthalmology) physician in Lake Mary, FL, with 20 years in practice. Based on federal Medicare data, Dr. Barnard performed 33,891 Medicare services across 7,071 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barnard received a total of $6,601 from 18 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barnard is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 15,480 | $29 | $79 |
| Aflibercept eye injection (Eylea) | 3,717 | $675 | $1,666 |
| Retinal imaging (OCT scan) | 3,444 | $30 | $78 |
| Eye injection for retinal disease | 2,559 | $99 | $479 |
| Comprehensive eye exam, established patient | 1,384 | $86 | $223 |
| Retinal photography (fundus photo) | 1,355 | $27 | $126 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,303 | $217 | $1,073 |
| Office visit, established patient (20-29 min) | 979 | $69 | $142 |
| Injection, ranibizumab, 0.1 mg | 892 | $179 | $626 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 705 | $120 | $635 |
| New patient office visit (45-59 min) | 320 | $122 | $320 |
| Compounded drug, not otherwise classified | 301 | $64 | $317 |
| Extended exam of the back part of the eye with optic nerve drawing | 272 | $11 | $80 |
| Eye exam, established patient, focused | 271 | $65 | $180 |
| Office visit, established patient (30-39 min) | 261 | $95 | $256 |
| Unclassified drugs | 222 | $1,119 | $3,517 |
| Steroid injection (triamcinolone) | 188 | $1 | $4 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 108 | $103 | $257 |
| Injection of drug or substance into membrane covering eyeball | 41 | $36 | $179 |
| 2d ultrasound scan of eye tissue and structures | 22 | $33 | $219 |
| Not otherwise classified, antineoplastic drugs | 20 | $67 | $330 |
| Comprehensive eye exam, new patient | 13 | $108 | $306 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 12 | $884 | $4,200 |
| Removal of eye fluid (vitreous) between lens and retina | 11 | $478 | $2,505 |
| Removal of membrane of retina | 11 | $901 | $3,018 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Barnard is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Barnard experienced with eye injection (vabysmo/faricimab)?
Does Dr. Barnard receive payments from pharmaceutical companies?
How do Dr. Barnard's costs compare to other retina specialist (ophthalmology) physicians in Lake Mary?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology